A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: TML-6 GranulesDrug: Placebo
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Merry Life Biomedical Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT06562114
- Locations
- 🇺🇸
Parexel International, Glendale, California, United States
© Copyright 2025. All Rights Reserved by MedPath